Follow The Filings

DFTX Definium Therapeutics

Health Care, filed as DEFINIUM THERAPEUTICS ORD (EQUITY), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2

  • 2 Owners
  • Max 0.3%
  • $41M
  • 2 new

In 2026 Q2 Stanley Druckenmiller and Ron Baron opened positions in Definium Therapeutics.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (Stanley Druckenmiller, Duquesne Family Office). Not free-float ownership.

  1. Stanley Druckenmiller New 0.32%
  2. Ron Baron New 0.04%

Who owns DFTX

Sorted by value, long equity only, as of 2026 Q2.

History
Ron Baron, Bamco Inc. (Baron Capital) 0.04% New 0.04% 520,108 $24M History
Stanley Druckenmiller, Duquesne Family Office 0.32% New 0.32% 356,600 $17M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by DFTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DFTX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 27 stock grants, 17 sales to cover taxes, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
SCHEDULE 13G —
8-K 7.01,8.01,9.01
8-K 8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 7.01,8.01,9.01
8-K 2.02,9.01
10-Q
424B5
8-K 1.01,8.01,9.01
8-K 7.01,8.01,9.01
424B5

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$95.73M -$108.68M -$183.79M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $103.87M $281.62M $419.32M
Total non-current assets * $20.67M $20.53M $20.78M
Total assets $124.54M $302.15M $440.1M
Total current liabilities $32.25M $38.85M $66.7M
Total non-current liabilities * $14.16M $21.85M $41.08M
Total equity $78.13M $241.45M $332.33M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$64.36M -$79.13M -$131.56M
Cash from investing — — -$151.61M
Cash from financing $21.85M $253.2M $267.27M
Net change in cash -$42.44M $174.04M -$15.9M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf